Dr. Hultcrantz, MD, PhD, is a hematologist-oncologist specializing in multiple myeloma and related plasma cell disorders. She serves as an Associate Attending Physician on the Myeloma Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and is an Associate Professor of Medicine at Weill Cornell Medicine. She is also a member of MSK’s Center for Hematologic Malignancies. Her clinical focus includes plasma cell disorders, immunotherapy and cellular therapies, and clinical trials that incorporate precision monitoring and supportive, quality-of-life-centered care. Her research interests include genomic and immune mechanisms of disease progression, population-based screening and epidemiology, and disparities and infectious complications in hematologic malignancies. Known for a deeply patient-centered approach, she is committed to bringing novel therapies from clinical trials to the bedside while helping patients and families navigate treatment with clarity and confidence. Dr. Hultcrantz has received the Multiple Myeloma Research Foundation Research Fellow Award and the Swedish Research Council International Postdoc Award, along with research support from Karolinska Institute Foundations, the Swedish Society of Medicine, and the Swedish Blood Cancer Foundation. She also contributes to national guideline development through the NCCN Guidelines for Multiple Myeloma. Dr. Hultcrantz earned her MD and PhD from Karolinska Institutet in Stockholm, Sweden. She completed her internal medicine residency at University Hospital Örebro, followed by fellowship training in hematology and internal medicine at Karolinska University Hospital and an advanced oncology fellowship at Memorial Sloan Kettering Cancer Center.
Associate Professor
Medical School
2000 – 2006
Residency
2008 – 2011
Fellowship
2011 – 2015